1-(Pyridin-4-ylmethyl)-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine, 98%, 250mg

(2,3-Dimethylphenyl)(1H-imidazol-4-yl)methanone, 95.0%, 100mg

LDPE-Enghalsflasche, Nalgene®,, Typ 2003, Inhalt 15 ml, 12 Stück

N-Fmoc-N,O-dimethyl-L-serine, 98%, 5g

(S)-2-(4-(tert-Butyl)-4,5-dihydrooxazol-2-yl)propan-2-ol, 95.0%, 1g

tert-Butylsulfinamide>97.0%(GC)5g

1-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide, 98%, 10mg

6-Bromo-4-hydroxy-2-(trifluoromethyl)quinoline, 95.0%, 5g

(E)-N'-((6-bromopyridin-3-yl)methylene)-4-methylbenzenesulfonohydrazide, 98%, 5g

4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 98%, 1g

4,4-Dimethoxytetrahydro-2H-pyran-3-ol, 97%, 250mg

Methyl 2-Bromo-5-nitrobenzoate>98.0%(GC)5g

Trimethylolpropane Tris(3-mercaptopropionate)>85.0%(GC)500g